| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.05B | +1.1% | +5.0% |
| Cost of Revenue | $429.5M | +0.7% | +5.1% |
| R&D Expense | $124.7M | -0.9% | +3.6% |
| SG&A Expense | $161.7M | -0.5% | +1.1% |
| Operating Income | $166.0M | +9.6% | +135.0% |
| Interest Expense | $7.9M | -3.5% | +17.5% |
| Pre-tax Income | $173.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $927.9M | +9.1% | +62.9% |
| Short-term Investments | $190.8M | +64.0% | -83.1% |
| Accounts Receivable | $765.9M | -1.7% | +10.0% |
| Current Assets | $2.17B | +6.6% | -17.7% |
| Total Assets | $10.83B | +2.8% | +6.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.15B | — | — |
| Capital Expenditures | $376.1M | — | — |
| Investing Cash Flow | -$174.4M | — | — |
| Financing Cash Flow | -$586.3M | — | — |
| Free Cash Flow | $776.1M | — | — |
| +14.0% |
| +134.6% |
| Income Tax | $33.0M | -31.7% | +107.5% |
| Net Income | $140.2M | +35.3% | +142.1% |
| EPS (Basic) | $0.98 | +36.1% | +157.9% |
| EPS (Diluted) | $0.97 | +36.6% | +155.3% |
| $950.3M |
| +7.9% |
| -52.1% |
| Total Liabilities | $6.10B | +0.5% | +13.1% |
| Stockholders' Equity | $4.73B | +5.9% | -1.3% |